IL-1Hy2Alternative Names: IL1Hy2; Interleukin-1 receptor antagonist protein IL1Hy2
Latest Information Update: 02 Jul 2004
At a glance
- Originator Nuvelo
- Mechanism of Action Interleukin 1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 02 Jul 2004 Discontinued - Preclinical for Rheumatoid arthritis in USA (unspecified route)
- 17 Feb 2000 Preclinical development for Rheumatoid arthritis in USA (Unknown route)